Dec. 04. 2025
Osaka, Japan – December 4, 2025 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Motohiko Kimura) today announced the listing of five generic drugs with 9 strengths in the NHI (National Health Insurance) drug price list. Sawai’s product line now includes 325 compounds with 761 strengths.
The list of new products
1. DAPAGLIFLOZIN Tablets
| Generic name | Dapagliflozin |
|---|---|
| Strengths | Tablets: 5mg, 10mg |
| Brand products | forxiga tablets 5mg, 10mg |
2. LACOSAMIDE Tablets, DS
| Generic name | Lacosamide |
|---|---|
| Strengths | Tablets: 50mg, 100mg DS: 10% |
| Brand products | VIMPAT® TABLETS 50mg, 100mg VIMPAT® DRY SYRUP 10% |
3. EFINACONAZOLE Solution
| Generic name | Efinaconazole |
|---|---|
| Strengths | Solution: 10% |
| Brand products | CLENAFIN® Topical Solution 10% |
4. NILOTINIB Capsules
| Generic name | Nilotinib |
|---|---|
| Strengths | Capsules: 150mg, 200mg |
| Brand products | Tasigna® Capsules 150mg, 200mg |
5. ABIRATERONE ACETATE Tablets
| Generic name | Abiraterone Acetate |
|---|---|
| Strengths | Tablets: 250mg |
| Brand products | ZYTIGA® tablets 250mg |
The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.